Ovid Therapeutics Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Ovid Therapeutics Inc. (OVID) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- Ovid Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.77M, a 116.99% increase year-over-year.
- Ovid Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$110.00K, a 283.33% decline year-over-year.
- Ovid Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $1.45M.
- Ovid Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$522.00K.
- Ovid Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $1.80M.
- Ovid Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$899.00K, a 164.91% decline from fiscal 2023.
- Ovid Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $1.39M.
- Ovid Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$109.29K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.67M 10-Q · filed 2026-08-13 | $3.11M derived: sum of 3 quarters · filed 2026-08-13 | $2.59M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$110.00K 10-Q · filed 2026-05-12 | $1.34M derived: sum of 2 quarters · filed 2026-05-12 | $814.00K derived: sum of 3 quarters · filed 2026-05-12 | $1.63M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $924.00K derived: sum of 2 quarters · filed 2026-03-18 | $1.74M derived: sum of 3 quarters · filed 2026-08-13 | $1.80M 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | -$522.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $296.00K derived: sum of 2 quarters · filed 2026-08-13 | $356.00K 10-Q · filed 2025-11-12 | $106.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $818.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $878.00K 10-Q · filed 2026-08-13 | $628.00K derived: sum of 3 quarters · filed 2026-08-13 | -$172.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $60.00K 10-Q · filed 2026-05-12 | -$190.00K derived: sum of 2 quarters · filed 2026-05-12 | -$990.00K derived: sum of 3 quarters · filed 2026-05-12 | $14.00K derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$1.05M derived: sum of 2 quarters · filed 2026-03-18 | -$46.00K derived: sum of 3 quarters · filed 2026-03-18 | -$899.00K 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | -$800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $204.00K derived: sum of 2 quarters · filed 2025-11-12 | -$649.00K 10-Q · filed 2025-11-12 | -$1.53M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $151.00K 10-Q · filed 2025-08-13 | -$726.00K derived: sum of 3 quarters · filed 2025-08-13 | -$2.51M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$853.00K 10-Q · filed 2025-05-13 | -$1.73M derived: sum of 2 quarters · filed 2025-05-13 | -$3.52M derived: sum of 3 quarters · filed 2025-05-13 | $790.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$877.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$2.66M derived: sum of 2 quarters · filed 2025-03-11 | $1.64M derived: sum of 3 quarters · filed 2025-03-11 | $1.39M 10-K · filed 2025-03-11 | $1.39M 10-K · filed 2024-03-08 | |||
| 2023-09-30 | -$1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.52M derived: sum of 2 quarters · filed 2024-11-12 | $2.26M 10-Q · filed 2024-11-12 | $2.26M 10-Q · filed 2023-11-03 | $2.00M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $4.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $4.05M 10-Q · filed 2024-08-13 | $4.05M 10-Q · filed 2023-08-04 | $3.78M derived: sum of 3 quarters · filed 2024-08-13 | $3.71M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$258.00K 10-Q · filed 2024-05-14 | -$258.23K 10-Q · filed 2023-05-05 | -$523.51K derived: sum of 2 quarters · filed 2024-05-14 | -$598.17K derived: sum of 3 quarters · filed 2024-05-14 | -$104.86K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$265.51K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$340.17K derived: sum of 2 quarters · filed 2024-03-08 | $153.15K derived: sum of 3 quarters · filed 2024-03-08 | -$109.29K 10-K · filed 2024-03-08 | ||||
| 2022-09-30 | -$74.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $418.66K derived: sum of 2 quarters · filed 2023-11-03 | $156.22K 10-Q · filed 2023-11-03 | -$493.53K derived: sum of 4 quarters · filed 2023-11-03 | ||||
| 2022-06-30 | $493.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $230.88K 10-Q · filed 2023-08-04 | -$418.87K derived: sum of 3 quarters · filed 2023-08-04 | -$833.62K derived: sum of 4 quarters · filed 2023-08-04 | ||||
| 2022-03-31 | -$262.44K 10-Q · filed 2023-05-05 | -$912.18K derived: sum of 2 quarters · filed 2023-05-05 | -$1.33M derived: sum of 3 quarters · filed 2023-05-05 | -$222.53K derived: sum of 4 quarters · filed 2023-05-05 | ||||
| 2021-12-31 | -$649.75K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$1.06M derived: sum of 2 quarters · filed 2023-03-13 | $39.91K derived: sum of 3 quarters · filed 2023-03-13 | -$40.50K 10-K · filed 2023-03-13 | -$14.09K 10-K · filed 2022-03-15 | |||
| 2021-09-30 | -$414.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $689.65K derived: sum of 2 quarters · filed 2022-11-08 | $609.24K 10-Q · filed 2022-11-08 | -$1.00M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.02M 10-Q · filed 2022-08-09 | -$589.21K derived: sum of 3 quarters · filed 2022-08-09 | -$51.17K derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$80.41K 10-Q · filed 2022-05-10 | -$1.69M derived: sum of 2 quarters · filed 2022-05-10 | -$1.16M derived: sum of 3 quarters · filed 2022-05-10 | -$891.79K derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$1.08M derived: sum of 2 quarters · filed 2022-03-15 | -$811.38K derived: sum of 3 quarters · filed 2022-03-15 | -$724.58K 10-K · filed 2022-03-15 | $724.58K 10-K · filed 2021-03-15 | |||
| 2020-09-30 | $538.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $801.82K derived: sum of 2 quarters · filed 2021-11-10 | $888.63K 10-Q · filed 2021-11-10 | $1.59M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $263.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $350.59K 10-Q · filed 2021-08-16 | $1.05M derived: sum of 3 quarters · filed 2021-08-16 | -$2.36M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $86.81K 10-Q · filed 2021-05-13 | $787.15K derived: sum of 2 quarters · filed 2021-05-13 | -$2.62M derived: sum of 3 quarters · filed 2021-05-13 | $104.66K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $700.34K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | -$2.71M derived: sum of 2 quarters · filed 2021-03-15 | $17.85K derived: sum of 3 quarters · filed 2021-03-15 | -$224.46K 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | -$3.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$682.49K derived: sum of 2 quarters · filed 2020-11-13 | -$924.80K 10-Q · filed 2020-11-13 | -$903.99K derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.48M 10-Q · filed 2020-08-10 | $2.50M derived: sum of 3 quarters · filed 2020-08-10 | $2.66M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$242.31K 10-Q · filed 2020-05-07 | -$221.50K derived: sum of 2 quarters · filed 2020-05-07 | -$69.50K derived: sum of 3 quarters · filed 2020-05-07 | $995.49K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $20.82K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $172.81K derived: sum of 2 quarters · filed 2020-03-11 | $1.24M derived: sum of 3 quarters · filed 2020-03-11 | $1.31M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.22M derived: sum of 2 quarters · filed 2019-11-08 | $1.28M 10-Q · filed 2019-11-08 | $1.49M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.13M 10-Q · filed 2019-08-07 | $1.34M derived: sum of 3 quarters · filed 2019-08-07 | $1.09M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $67.25K 10-Q · filed 2019-05-07 | $271.82K derived: sum of 2 quarters · filed 2019-05-07 | $26.19K derived: sum of 3 quarters · filed 2019-05-07 | $692.65K derived: sum of 4 quarters · filed 2019-05-07 | ||||
| 2017-12-31 | $204.58K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$41.06K derived: sum of 2 quarters · filed 2019-03-07 | $625.40K derived: sum of 3 quarters · filed 2019-03-07 | $793.26K 10-K · filed 2019-03-07 | ||||
| 2017-09-30 | -$245.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $420.83K derived: sum of 2 quarters · filed 2018-11-08 | $588.68K 10-Q · filed 2018-11-08 | $628.00K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $666.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $834.31K 10-Q · filed 2018-08-09 | $873.64K derived: sum of 3 quarters · filed 2018-08-09 | $102.29K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $167.85K 10-Q · filed 2018-05-08 | $207.18K derived: sum of 2 quarters · filed 2018-05-08 | -$564.17K derived: sum of 3 quarters · filed 2018-05-08 | $269.61K derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | $39.33K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | -$732.02K derived: sum of 2 quarters · filed 2018-03-29 | $101.76K derived: sum of 3 quarters · filed 2018-03-29 | -$58.83K 10-K · filed 2018-03-29 | ||||
| 2016-09-30 | -$771.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $62.43K derived: sum of 2 quarters · filed 2017-11-09 | -$98.15K 10-Q · filed 2017-11-09 | |||||
| 2016-06-30 | $833.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $673.20K 10-Q · filed 2017-08-10 | ||||||
| 2016-03-31 | -$160.58K 10-Q · filed 2017-06-13 | |||||||
| 2015-12-31 | $279.56K 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |